FHA
SPPI

Flagship Harbor Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Flagship Harbor Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-615
Closed -$2K – 1893
2020
Q3 		$2K Hold
615
– – ﹤0.01% 1775
2020
Q2 		$2K Hold
615
– – ﹤0.01% 1862
2020
Q1 		$1K Hold
615
– – ﹤0.01% 1829
2019
Q4 		$2K Hold
615
– – ﹤0.01% 1757
2019
Q3 		$5K Hold
615
– – ﹤0.01% 1519
2019
Q2 		$5K Hold
615
– – ﹤0.01% 1523
2019
Q1 		$6K Hold
615
– – ﹤0.01% 1465
2018
Q4 		$5K Hold
615
– – ﹤0.01% 1469
2018
Q3 		$10K Buy
+615
New +$13.3K ﹤0.01% 1441

Other funds holding SPPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Flagship Harbor Advisors's SPPI Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2020, closing a stake of 615 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in SPPI in Q3 2018 and held it in 9 quarters. The position peaked at $10K in Q3 2018. 161 funds tracked by Wall St. Rank hold SPPI as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 615 Spectrum Pharmaceuticals Inc shares in Q4 2020, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 9 quarters.
  • Flagship Harbor Advisors's Spectrum Pharmaceuticals Inc position peaked at $10K in Q3 2018.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.